Cubist Systematic Strategies LLC acquired a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 64,912 shares of the company’s stock, valued at approximately $241,000.
A number of other hedge funds have also modified their holdings of CDLX. Mirabella Financial Services LLP purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $4,285,000. Rangeley Capital LLC purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $1,187,000. RBF Capital LLC increased its stake in shares of Cardlytics by 64.7% during the 4th quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock worth $2,982,000 after purchasing an additional 315,635 shares in the last quarter. Natixis purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $462,000. Finally, Bridgeway Capital Management LLC purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $416,000. 68.10% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, CFO Alexis Desieno sold 24,778 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the sale, the chief financial officer now directly owns 140,948 shares of the company’s stock, valued at $479,223.20. The trade was a 14.95% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at $1,423,365.80. This represents a 10.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 71,938 shares of company stock valued at $244,017 in the last ninety days. Company insiders own 4.40% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on CDLX
Cardlytics Stock Up 3.5%
Shares of NASDAQ CDLX opened at $2.06 on Friday. Cardlytics, Inc. has a 52-week low of $1.22 and a 52-week high of $9.85. The firm has a fifty day moving average of $1.81 and a 200-day moving average of $2.90. The stock has a market capitalization of $108.15 million, a PE ratio of -0.34 and a beta of 1.30. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.
Cardlytics Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- Why Are These Companies Considered Blue Chips?
- Top 4 ETFs for China Exposure After Tariff Relief
- 3 Dividend Kings To Consider
- Build a Complete Bond Portfolio With These 4 ETFs
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 05/12 – 05/16
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLX – Free Report).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.